Development of a Microfluidic Open Source 3D bioprinting System (MOS3S) for the engineering of hierarchical tissues
Not a formal paper link, but a recent open repository that may correspond to a paper; good lead.
- Year
- 2024
- Skill
- medium
- Docs
- moderate
- Rubric
- 3.6 / 5
Implementation assessment
Scoring by criterion
Scores describe accessibility and implementation characteristics reported in the reviewed source. They are not a measure of scientific quality.
Resolution
Quantitative handling accuracy reported, but minimum volume unclear.
Scalability/Throughput
Moderate scalability via modularity, batching, or partial automation.
Build and Part Sourcing Complexity
Mix of common parts and custom/printed components.
Skill Complexity
Build/operation described as low-skill or basic assembly.
Equipment/Cosumable/Facility Requirement Accessibility
Uses common benchtop/desktop equipment or generic consumables.
Application Level
Supports broad or translationally relevant applications.
Accessibility to documentation
Open resources include several build or operation artifacts.
Validation/Troubleshooting Complexity
Validation includes standards, benchmarking, replicates, or multi-condition tests.
Speed/Cycle Time
Speed/cycle time not reported; assigned neutral score.
Build Time
Build time not reported; assigned neutral score.
Record metadata
Publication data
Crossref and OpenAlex
Publication record
Abstract
The development of 3D bioprinting has shown great promise in the field of tissue engineering and disease modelling. However, the high cost of commercial 3D bioprinters has limited their accessibility, especially to those laboratories in resource-limited settings. Moreover, the need for a 3D bioprinting system capable of handling multi-material is growing. Therefore, the development of low-cost 3D bioprinters is necessary to make this technology accessible to a wider range of researchers. We have developed a customized, open-source, low-cost 3D bioprinter based on a commercial fused deposition modeling (FDM) 3D printer to address this issue. The bioprinter is designed to print biomaterials for tissue engineering purposes using a coaxial nozzle for in situ cross-linking the biomaterial, and it includes three syringe pumps that can also be used to deliver liquid in microfluidic chips. The affordability of our bioprinter is a significant advantage, as it makes it accessible to a broader spectrum of users, working in different fields such as tissue engineering, drug discovery, and disease modeling. The open-source nature of the bioprinter also allows for easy customization and adaptation to specific research needs. The performance of the 3D bioprinter has been validated by constructing lattice scaffolds which are being widely used in tissue engineering.
Bibliographic details
Access and metrics
Topics and keywords
Perspective and practical signals
Why it matters
Not a formal paper link, but a recent open repository that may correspond to a paper; good lead.
Limitations
No limitation note curated yet.